Atox Bio Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 27
Employees
  • Latest Deal Type
  • Series F
  • Latest Deal Amount
  • $33M
Latest Deal Amount
  • Investors
  • 11

Atox Bio General Information

Description

Developer of novel immunomodulators created to improve outcomes for serious, unmet medical conditions in the critical care setting. The company's lead product is initially being developed to treat a rare, life-threatening infection with high morbidity and mortality whose results have shown a meaningful improvement across multiple endpoints, enabling healthcare institutions to significantly improve the hosts' ability to effectively fight the infection and reduce the tissue damage caused to key organs during acute inflammatory situations.

Contact Information

Website
www.atoxbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 1000 Park Forty Plaza
  • Suite 360
  • Durham, NC 27713
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atox Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series F) 30-Apr-2019 $33M 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 24-Jul-2014 0000 000.00 Completed Generating Revenue
4. Later Stage VC 19-Dec-2011 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 13-Oct-2010 00.00 00.00 Completed Generating Revenue
2. Angel (individual) Completed Startup
1. Grant Completed Startup
To view Atox Bio’s complete valuation and funding history, request access »

Atox Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel immunomodulators created to improve outcomes for serious, unmet medical conditions in the critical ca
Biotechnology
Durham, NC
27 As of 2021
000.00
00000000000 000.00

000000 0

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000 000000000
Durham, NC
00 As of 0000
000.00
0000000000 000.00

00000000

n voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000000000000
Waltham, MA
00 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atox Bio Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Parion Sciences Venture Capital-Backed Durham, NC 00 000.00 0000000000 000.00
00000000 Formerly VC-backed Waltham, MA 00 00000 000000&0 00000
0000 000000000000 Formerly VC-backed San Diego, CA 000 00000 00000000 00000
000000 Venture Capital-Backed Ann Arbor, MI 00 00000 000000000 - 00000
000000 0000 000000 Corporation New York, NY 00 000.00 000000 - 000 000.00
You’re viewing 5 of 13 competitors. Get the full list »

Atox Bio Executive Team (9)

Name Title Board Seat Contact Info
Dan Teleman Chief Executive Officer
Esti Hayun Chief Financial Officer
Raymond Kaempfer Ph.D Co-Founder & Chief Scientist
Anat Shirvan Ph.D Executive Vice President, Research & Development
Gila Arad Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

Atox Bio Board Members (11)

Name Representing Role Since
Bob Trachtenberg Self Board Member 000 0000
Casper Breum Lundbeckfond Ventures Board Member 000 0000
Dane Ross Atox Bio Board Member 000 0000
Daniel Burgess Self Chairman 000 0000
Dean Slagel Esperante Ventures Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Atox Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atox Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adams Street Partners Fund of Funds Minority 000 0000 000000 0
Arix Bioscience Venture Capital Minority 000 0000 000000 0
Asahi Kasei Corporate Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
Integra Holdings Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »